This inventor holds 1 USPTO granted patent. Top assignee: Shanghai East Hospital. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: **Innovative Contributions of Inventor Dan Shi in Ion Channel Research**
Introduction
Dan Shi, an accomplished inventor based in Shanghai, China, is known for his significant contributions to the field of pharmacology, particularly in the development of ion channel antagonists. With a focus on creating compounds that can be utilized in treating heart diseases and other ion channel-related conditions, Dan's work has the potential to impact millions of lives.
Latest Patents
Dan Shi holds one notable patent titled "Ion channel antagonists/blockers and uses thereof." This patent provides innovative compounds classified under a specific formula, which includes pharmaceutically acceptable salts, stereoisomers, solvates, and prodrugs. The preparations and applications of these compounds aim to form effective pharmaceutical compositions to treat heart disease and other related ailments associated with ion channel dysfunctions.
Career Highlights
Dan works at Shanghai East Hospital, where he applies his expertise in pharmacological research. His dedication to advancing medical science is evident through his patent and the potential applications of his work. The development of ion channel antagonists showcases his innovative approach to addressing complex health issues.
Collaborations
Collaboration plays a crucial role in Dan Shi's research endeavors. He collaborates with talented individuals like Yihan Chen and Dandan Liang, which fosters a dynamic environment for innovation and shared knowledge. Together, they contribute to the advancement of medical research and the therapeutic potential of their findings.
Conclusion
Dan Shi's innovative work in ion channel research illustrates the importance of inventors in the realm of medicine. His patented ion channel antagonists represent a significant step forward in the treatment of heart disease and related health issues. As he continues to collaborate with fellow researchers, the potential for further advancements in the pharmaceutical field remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile